Aristeia Capital’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-164,255
| Closed | -$250K | – | 419 |
|
2024
Q1 | $250K | Sell |
164,255
-194,078
| -54% | -$296K | 0.01% | 155 |
|
2023
Q4 | $31.3K | Hold |
358,333
| – | – | ﹤0.01% | 122 |
|
2023
Q3 | $57.3K | Buy |
358,333
+25,000
| +8% | +$4K | ﹤0.01% | 131 |
|
2023
Q2 | $28.3K | Hold |
333,333
| – | – | ﹤0.01% | 180 |
|
2023
Q1 | $21.9K | Hold |
333,333
| – | – | ﹤0.01% | 296 |
|
2022
Q4 | $12.5K | Hold |
333,333
| – | – | ﹤0.01% | 435 |
|
2022
Q3 | $25K | Hold |
333,333
| – | – | ﹤0.01% | 544 |
|
2022
Q2 | $52K | Hold |
333,333
| – | – | ﹤0.01% | 507 |
|
2022
Q1 | $105K | Buy |
+333,333
| New | +$105K | ﹤0.01% | 540 |
|